CC BY-NC-ND 4.0 · Homeopathy 2009; 98(04): 287-298
DOI: 10.1016/j.homp.2009.09.006
Original Paper

Reporting experiments in homeopathic basic research (REHBaR) – A detailed guideline for authors

B. Stock-Schröer
1   Karl and Veronica Carstens-Foundation, D-Essen, Germany
H. Albrecht
1   Karl and Veronica Carstens-Foundation, D-Essen, Germany
L. Betti
2   Department of Agro-Environmental Science and Technology, Faculty of Agriculture, Bologna University, I-Bologna, Italy
P.C. Endler
3   Interuniversity College for Health and Development, A-Graz, Austria
K. Linde
4   Institute of General Practice, Technical University, D-Munich, Germany
R. Lüdtke
1   Karl and Veronica Carstens-Foundation, D-Essen, Germany
F. Musial
5   Department of Complementary and Integrative Medicine, University of Duisburg-Essen, D-Essen, Germany
R. van Wijk
6   International Institute of Biophysics, D-Neuss, Germany
C. Witt
7   Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, D-Berlin, Germany
S. Baumgartner
8   Institute of Complementary Medicine KIKOM, University of Bern, CH-Bern, Switzerland
› Author Affiliations

Background: Reporting experiments in basic research in homeopathy is an important issue as comprehensive description of what exactly was done is required. So far, there is no guideline for authors available, unlike criteria catalogues common in clinical research.

Methods: A Delphi Process was conducted, including a total of five rounds, three rounds of adjusting and phrasing plus two consensus conferences. European researchers who published experimental work within the last five years were involved.

Results: A checklist of 23 items was obtained and supplemented with detailed examples emphasizing what each item implies. Background, objectives and possible hypotheses should be given in the part ‘introduction’. Special emphasis is put on the ‘materials and methods’ section, where a detailed description of chosen controls, object of investigation, experimental setup, replication, parameters, intervention, allocation, blinding, and statistical methods is required. The section ‘results’ should present sufficient details on analysed data, descriptive as well as inferential. Authors should discuss their results and give an interpretation in the context of current evidence.

Conclusion: A guideline for Reporting Experiments in Homeopathic Basic Research (REHBaR) was compiled to be applied by authors when preparing their manuscripts, and to be used by scientific journals in the reviewing process. Furthermore the guideline is a commitment to a certain minimum quality level needed in basic research, e.g. blinding and randomisation. Feedback is encouraged on applicability, strength and limitations of the list to enable future revisions.

Publication History

Received: 22 June 2009
Received: 10 September 2009

Accepted: 16 September 2009

Article published online:
20 December 2017

© 2009. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

  • References

  • 1 Begg C., Cho M., Eastwood S. et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. Jama 1996; 276 (08) 637-639
  • 2 Moher D., Schulz K.F., Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357 (9263): 1191-1194
  • 3 Moher D., Schulz K.F., Altman D. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. Explore (NY) 2005; 1 (01) 40-45
  • 4 Hopewell S., Clarke M., Moher D. et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med 2008; 5 (01) e20
  • 5 Zwarenstein M., Treweek S., Gagnier J.J. et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. Bmj 2008; 337: a2390
  • 6 Boutron I., Tubach F., Giraudeau B., Ravaud P. Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. Jama 2003; 290 (08) 1062-1070
  • 7 Simera I., Moher D., Hoey J., Schulz K.F., Altman D.G. The EQUATOR Network and reporting guidelines: Helping to achieve high standards in reporting health research studies. Maturitas 2009; 63 (01) 4-6
  • 8 Moher D., Cook D.J., Eastwood S. et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354 (9193): 1896-1900
  • 9 Turpin D.L. CONSORT and QUOROM guidelines for reporting randomized clinical trials and systematic reviews. Am J Orthod Dentofacial Orthop 2005; 128 (06) 681-685 (discussion 686)
  • 10 Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. J Clin Epidemiol 2009
  • 11 Vandenbroucke J.P., von Elm E., Altman D.G. et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med 2007; 147 (08) W163-W194
  • 12 Little J., Higgins J.P., Ioannidis J.P. et al. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med 2009; 6 (02) e22
  • 13 MacPherson H., White A., Cummings M. et al. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. Complement Ther Med 2001; 9 (04) 246-249
  • 14 Davidoff F., Batalden P., Stevens D., Ogrinc G., Mooney S.E. Publication guidelines for quality improvement studies in health care: evolution of the SQUIRE project. Bmj 2009 338: a3152
  • 15 Bossuyt P.M., Reitsma J.B., Bruns D.E. et al. Toward complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Acad Radiol 2003; 10 (06) 664-669
  • 16 Dean M.E., Coulter M.K., Fisher P., Jobst K.A., Walach H. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. J Altern Complement Med 2007; 13 (01) 19-23
  • 17 Van Wijk R., Albrecht H. Classification of systems and methods used in biological basic research on homeopathy. Homeopathy 2007; 96 (04) 247-251
  • 18 Schulte J. About Quality and standards in Ultra High Dilution Research and Research on Homeopathy. In: Endler P.C.S. Ultra High Dilution - Physiology and Physics. 1994. Dordrecht: Kluwer Academic Publishers; 171-176
  • 19 Linde K., Melchart D., Jonas W.B., Hornung J. Ways to enhance the quality and acceptance of clinical and laboratory studies in homeopathy. Brit Hom J 1994; 83 (01) 3-7
  • 20 Baumgartner S., Heusser P., Thurneysen A. Methodological Standards and Problems in Preclinical Homoeopathic Potency Research. Forsch Komplementarmed 1998; 5 (01) 27-32
  • 21 Linde K., Jonas W.B., Melchart D. et al. Critical review and meta-analysis of serial agitated dilutions in experimental toxicology. Hum Exp Toxicol 1994; 13 (07) 481-492
  • 22 Becker-Witt C., Weisshuhn T.E., Ludtke R., Willich S.N. Quality assessment of physical research in homeopathy. J Altern Complement Med 2003; 9 (01) 113-132
  • 23 Hornung J., Linde K. Guidelines for the Exact Description of the Preparation and Mode of Application of Serial Dilutions and Potencies in Publications on Ultra Low Dose Effects and Homeopathic Research - a proposal-. The Berlin Journal on Research in Homeopathy 1991; 1 (02) 121-123
  • 24 Linstone H., Turoff M. The Delphi Method: Techniques and Applications . 2002
  • 25 Verhagen A.P., de Vet H.C., de Bie R.A. et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51 (12) 1235-1241
  • 26 Flower A., Lewith G.T., Little P. Seeking an oracle: using the Delphi process to develop practice guidelines for the treatment of endometriosis with Chinese herbal medicine. J Altern Complement Med 2007; 13 (09) 969-976
  • 27 Stock-Schröer B., Albrecht H., Betti L. et al. Reporting Experiments in Homeopathic Basic Research (REHBaR) – Description of the Checklist Development. eCAM 2009 (submitted)
  • 28 Cesar B., Abud A.P., de Oliveira C.C. et al. Activation of mononuclear bone marrow cells treated in vitro with a complex homeopathic medication. Micron 2008; 39 (04) 461-470
  • 29 Baumgartner S., Thurneysen A., Heusser P. Growth stimulation of dwarf peas (Pisum sativum L.) through homeopathic potencies of plant growth substances. Forsch Komplementarmed Klass Naturheilkd 2004; 11 (05) 281-292
  • 30 Velkers F.C., te Loo A.J., Madin F., van Eck J.H. Isopathic and pluralist homeopathic treatment of commercial broilers with experimentally induced colibacillosis. Res Vet Science 2005; 78 (01) 77-83
  • 31 Nani D., Brizzi M., Lazzarato L., Betti L. The role of variability in evaluating ultra high dilution effects: considerations based on plant model experiments. Forsch Komplement Med (2006) 2007; 14 (05) 301-305
  • 32 Brack A., Strube J., Stolz P., Decker H. Effects of ultrahigh dilutions of 3,5-dichlorophenol on the luminescence of the bacterium Vibrio fischeri. Biochim Biophys Acta 2003; 1621 (03) 253-260
  • 33 Chirumbolo S., Brizzi M., Ortolani R., Vella A., Bellavite P. Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study. Inflamm Res 2009
  • 34 Walchli C., Baumgartner S., Bastide M. Effect of low doses and high homeopathic potencies in normal and cancerous human lymphocytes: an in vitro isopathic study. J Altern Complement Med 2006; 12 (05) 421-427
  • 35 Weber S., Endler P.C., Welles S.U. et al. The effect of homeopathically prepared thyroxine on highland frogs: influence of electromagnetic fields. Homeopathy 2008; 97 (01) 3-9
  • 36 Wiegant F.A., Souren J.E., van Rijn J., van Wijk R. Stressor-specific Induction of Heat Shock Proteins in Rat Hepatoma Cells. Toxicology 1994; 94: 143-159
  • 37 van Wijk R., Bosman S., van Wijk E.P. Thermoluminescence in Ultra-High Dilution Research. J Altern Complement Med 2006; 12 (05) 437-443
  • 38 Brizzi M., Lazzarato L., Nani D. et al. A biostatistical insight into the As(2)O(3) high dilution effects on the rate and variability of wheat seedling growth. Forsch Komplementarmed Klass Naturheilkd 2005; 12 (05) 277-283
  • 39 Elia V.E., Montanino L., Napoli E., Niccoli M., Nonatelli L. Conductometric studies of the serially diluted and agitated solutions on an anomalous effect that depends on the dilution process. J. Molecular Liquids 2007; 135: 158-165
  • 40 Cazin J.C., Cazin M., Gaborit J.L. et al. A Study of the Effect of Decimal and Centesimal Dilutions of Arsenic on the Retention and Mobilization of Arsenic in the Rat. Human Toxicol 1987; 6: 315-320
  • 41 Witt C.M., Bluth M., Hinderlich S. et al. Does potentized HgCl2 (Mercurius corrosivus) affect the activity of diastase and alpha-amylase?. J Altern Complement Med 2006; 12 (04) 359-365
  • 42 Scherr C., Simon M., Spranger J., Baumgartner S. Effects of potentised substances on growth rate of the water plant Lemna gibba L. Complement Ther Med 2009; 17 (02) 63-70
  • 43 Baumgartner S., Shah D., Schaller J. et al. Reproducibility of dwarf pea shoot growth stimulation by homeopathic potencies of gibberellic acid. Complement Ther Med 2008; 16 (04) 183-191
  • 44 Witt C., Ludtke R., Weisshuhn T.E., Willich S.N. High homeopathic potencies are different from potentized solvent when investigated with the REDEM technology. Forsch Komplementarmed Klass Naturheilkd 2005; 12 (01) 6-13
  • 45 Wiegant F.A., Souren J.E., van Wijk R. Stimulation of survival capacity in heat shocked cells by subsequent exposure to minute amounts of chemical stressors; role of similarity in hsp-inducing effects. Hum Exp Toxicol 1999; 18 (07) 460-470
  • 46 Folkes A., Urquhart R., Grunfeld E. Are leading medical journals following their own policies on CONSORT reporting?. Contemp Clin Trials 2008; 29 (06) 843-846
  • 47 Brand R.A. Standards of reporting: the CONSORT, QUORUM, and STROBE guidelines. Clin Orthop Relat Res 2009; 467 (06) 1393-1394
  • 48 Rios L.P., Odueyungbo A., Moitri M.O., Rahman M.O., Thabane L. Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinol Metab 2008; 93 (10) 3810-3816
  • 49 Berwanger O., Ribeiro R.A., Finkelsztejn A. et al. The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals. J Clin Epidemiol 2009; 62 (04) 387-392
  • 50 Han C., Kwak K.P., Marks D.M. et al. The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. Contemp Clin Trials 2009; 30 (02) 116-122
  • 51 Prady S.L., Richmond S.J., Morton V.M., Macpherson H. A systematic evaluation of the impact of STRICTA and CONSORT recommendations on quality of reporting for acupuncture trials. PLoS ONE 2008; 3 (02) e1577
  • 52 Knobloch K., Gohritz A., Vogt P.M. CONSORT and QUOROM statements revisited: standards of reporting of randomized controlled trials in general surgery. Ann Surg 2008; 248 (06) 1106-1107 (discussion 1107-8)
  • 53 Vandenbroucke J.P. STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK. and CONSORT: for whom does the guideline toll?. J Clin Epidemiol 2009; 62 (06) 594-596
  • 54 Baumgartner S, The State of Basic Research on Homeopathy, in New Directions in Homeopathy Research – Advice From an Interdisciplinary Conference, In: Albrecht H, Witt C (Eds). KVC-Verlag: Essen, 2009.